Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TYO/4554 stock hub

TYO/4554 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYO/4554is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

57.6B

Tokyo Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TYO/4554

In the news

Latest news · TYO/4554

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.3

P25 12.7P50 15.8P75 21.7

Trailing P/E23.5

P25 11.7P50 15.2P75 22.3

ROE4.9

P25 -1.6P50 7.1P75 11.9

ROIC7.4

P25 -0.6P50 6.2P75 14.3

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYO/4554 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

217

Groups with data

Currency

JPY

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	JP
Employees	1,760
Employees Change	102%
Employees Change Percent	6.15
Enterprise value	JPY 84.7B
Exchange	Tokyo Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	JP3816200004
Last refreshed	2026-05-10
Market cap	JPY 57.6B
Price	JPY 2,244
Price currency	JPY
Rev Per Employee	31,007,954.55x
Sector	Healthcare
Sic	2834
Symbol	tyo/4554
Website	https://www.fujipharma.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.05%
EV Earnings	36.31x
EV/EBIT	12.98x
EV/EBITDA	8.02x
EV/Sales	1.55x
Forward P/E	15.29x
P/B ratio	1.2x
P/E ratio	23.5x
P/S ratio	1.06x
PE Ratio10 Y	13.45x
PE Ratio3 Y	10.08x
PE Ratio5 Y	9.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.96%
EBITDA Margin	19.36%
Gross margin	40.82%
Gross Profit	JPY 22.3B
Gross Profit Growth	13.68%
Gross Profit Growth Q	28.54%
Gross Profit Growth3 Y	15.16%
Gross Profit Growth5 Y	8.46%
Net Income	JPY 2.3B
Net Income Growth	-46.95%
Net Income Growth Q	-67.31%
Net Income Growth Years	0%
Net Income Growth3 Y	-4.66%
Net Income Growth5 Y	-2.65%
Pretax Margin	5.17%
Profit Margin	4.27%
Profit Per Employee	JPY 1.3M
Profitable Years	22
ROA	4.31
Roa5y	3.17
ROCE	10.4
ROE	4.88
Roe5y	8.83
ROIC	7.41
Roic5y	5.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.42%
Cagr15y	9.93%
Cagr1y	68.33%
Cagr20y	8.38%
Cagr3y	24.76%
Cagr5y	16.22%
Div CAGR10	7.98%
Div CAGR3	9.44%
Div CAGR5	10.83%
EPS Growth	-47.22
EPS Growth Q	-67.48
EPS Growth Years	0
EPS Growth3 Y	-4.84
EPS Growth5 Y	2.2
Revenue Growth	12.78x
Revenue Growth Q	22.29x
Revenue Growth Quarters	17x
Revenue Growth Years	5x
Revenue Growth3 Y	14.9x
Revenue Growth5 Y	9.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	JPY 0.58
Assets	JPY 95.1B
Cash	JPY 3.4B
Current Assets	JPY 50.7B
Current Liabilities	JPY 32.3B
Debt	JPY 30.5B
Debt EBITDA	JPY 2.88
Debt Equity	JPY 0.64
Equity	JPY 47.9B
Interest Coverage	19.31
Liabilities	JPY 47.1B
Long Term Assets	JPY 44.4B
Long Term Liabilities	JPY 14.8B
Net Cash	JPY -27.1B
Net Cash By Market Cap	JPY -46.97
Net Debt EBITDA	JPY 2.56
Net Debt Equity	JPY 0.56
Tangible Book Value	JPY 34B
Tangible Book Value Per Share	JPY 1,389
WACC	4.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.57
Inventory Turnover	1.49
Net Working Capital	JPY 33.1B
Quick ratio	0.83
Working Capital	JPY 18.4B
Working Capital Turnover	JPY 4.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.5%
Dividend Growth	14.12%
Dividend Growth Years	4%
Dividend per share	JPY 47
Dividend Years	32
Dividend Yield	2.09%
Ex Div Date	2026-03-30
Last Dividend	JPY 23
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	194.92%
1Y total return	68.27%
200-day SMA	1,841.1
3Y total return	94.21%
50-day SMA	2,346.7
50-day SMA vs 200-day SMA	50over200
5Y total return	111.97%
All Time High	2,620
All Time High Change	-14.35%
All Time High Date	2018-04-05
All Time Low	142.5
All Time Low Change	1,474.74%
All Time Low Date	1997-12-24
ATR	71.24
Beta	0.31
Beta1y	0.31
Beta2y	0.59
Ch YTD	18.86
High	2,273
High52	2,559
High52 Date	2026-03-27
High52ch	-12.31%
Low	2,210
Low52	1,233
Low52 Date	2025-05-15
Low52ch	82%
Ma50ch	-4.37%
Price vs 200-day SMA	21.88%
RSI	42.23
RSI Monthly	69.84
RSI Weekly	57.27
Sharpe ratio	1.73x
Sortino ratio	3.31
Total Return	1.59%
Tr YTD	19.95
Tr15y	313.61%
Tr1m	-10.17%
Tr1w	4.18%
Tr3m	4.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	JPY 6.5B
Operating Income Growth	23.76
Operating Income Growth Q	122.2
Operating Income Growth3 Y	24.21
Operating Income Growth5 Y	11.51
Operating margin	11.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,893,063%
Shares Insiders	39.42%
Shares Institutions	14.63%
Shares Out	25,685,235
Shares Qo Q	0.04%
Shares Yo Y	0.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	92,600x
Bv Per Share	1,959.4
Ch10y	132.5
Ch15y	193.3
Ch1m	-10.17
Ch1w	4.18
Ch1y	64.04
Ch20y	229
Ch3m	3.17
Ch3y	78.24
Ch5y	82.74
Ch6m	42.48
Change	0.54%
Change From Open	-0.71
Close	2,232
Days Gap	1.25
Depreciation Amortization	4,036,250,000
Dollar Volume	200,838,000
Earnings Date	2026-05-07
EBIT	JPY 6.5B
EBITDA	JPY 10.6B
EPS	JPY 95.47
F Score	5
Fiscal Year End	September
Founded	1,965
Graham Number	2051.56359
Graham Upside	-8.58
Income Tax	JPY 491M
Is Primary Listing	1
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Last Split Date	2018-06-27
Last Split Type	Forward
Lynch Fair Value	JPY 477
Lynch Upside	-78.73
Ma150	1,970.7
Ma150ch	13.87%
Ma20	2,361.8
Ma20ch	-4.99%
Open	2,260
Payment Date	2026-06-02
Position In Range	53.97
Ppne	20,960,000,000
Price Date	2026-05-08
Price EBITDA	JPY 5.46
Ptbv Ratio	1.7
Relative Volume	0.99x
Revenue	54,574,000,000x
Tax By Revenue	0.9x
Tax Rate	17.39%
Tr20y	399.68%
Tr6m	43.79%
Volume	89,500
Z Score	2.02

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TYO/4554 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.1%

$47.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.8%

4 consecutive years of growth

Total shareholder yield

+1.6%

Next ex-dividend date: 2026-03-30

Performance

TYO/4554 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYO/4554?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.6%

Share of float held by funds and institutions

Insider ownership

+39.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

TYO/4554 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.2

Neutral momentum band

Price vs 200-day MA

+21.9%

50/200-day relationship not available

Beta (5Y)

0.31

Less volatile than the market

Sharpe ratio

1.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYO/4554

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4554 stock rating?

tyo/4554 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4554 analysis?

The full report lives at /stocks/tyo/4554/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4554?

The latest report frames tyo/4554 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4554 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.